Total Payments
$1.3M
2024 Payments
$158,205
Companies
9
Transactions
1,133
Medicare Patients
247
Medicare Billing
$22,271
Payment Breakdown by Category
Other$1.0M (82.0%)
Travel$129,214 (10.3%)
Consulting$71,078 (5.6%)
Food & Beverage$26,975 (2.1%)
Education$153.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.0M | 422 | 81.6% |
| Travel and Lodging | $129,214 | 317 | 10.3% |
| Consulting Fee | $71,078 | 28 | 5.6% |
| Food and Beverage | $26,975 | 359 | 2.1% |
| Honoraria | $4,000 | 2 | 0.3% |
| Education | $153.72 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $499,258 | 515 | $0 (2024) |
| ViiV Healthcare Company | $368,605 | 245 | $0 (2024) |
| Janssen Products, LP | $309,418 | 278 | $0 (2023) |
| Merck Sharp & Dohme LLC | $41,416 | 55 | $0 (2022) |
| EMD Serono, Inc. | $33,214 | 17 | $0 (2024) |
| Theratechnologies Inc. | $6,535 | 7 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $1,300 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $231.68 | 13 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $66.56 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158,205 | 105 | ViiV Healthcare Company ($99,323) |
| 2023 | $129,485 | 102 | ViiV Healthcare Company ($72,731) |
| 2022 | $162,121 | 116 | ViiV Healthcare Company ($82,295) |
| 2021 | $104,881 | 75 | ViiV Healthcare Company ($47,397) |
| 2020 | $103,332 | 83 | Gilead Sciences, Inc. ($42,538) |
| 2019 | $187,413 | 181 | Gilead Sciences, Inc. ($99,504) |
| 2018 | $194,028 | 211 | Gilead Sciences, Inc. ($100,973) |
| 2017 | $220,579 | 260 | Gilead Sciences Inc ($120,194) |
All Payment Transactions
1,133 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/30/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: HIV | ||||||
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $118.57 | General |
| Category: HIV | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: HIV | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Travel and Lodging | In-kind items and services | $403.92 | General |
| Category: HIV | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: HIV | ||||||
| 11/22/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $92.23 | General |
| Category: HIV | ||||||
| 11/21/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $122.34 | General |
| Category: HIV | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: HIV | ||||||
| 10/21/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,150.00 | General |
| Category: HIV | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: HIV | ||||||
| 10/11/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 10/09/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 10/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 09/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 09/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 09/20/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $45.88 | General |
| 09/20/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $31.32 | General |
| 09/20/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 09/20/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $11.99 | General |
| 09/17/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | In-kind items and services | $788.43 | General |
| Category: HIV | ||||||
| 09/17/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $103.58 | General |
| Category: HIV | ||||||
| 09/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: HIV | ||||||
| 09/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $885.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 46 | 94 | $17,578 | $4,408 |
| 2022 | 2 | 59 | 124 | $22,852 | $6,226 |
| 2021 | 2 | 67 | 142 | $26,278 | $6,980 |
| 2020 | 2 | 75 | 129 | $21,226 | $4,656 |
Total Patients
247
Total Services
489
Medicare Billing
$22,271
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 46 | 94 | $17,578 | $4,408 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 44 | 96 | $17,952 | $4,771 | 26.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 15 | 28 | $4,900 | $1,455 | 29.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 48 | 119 | $22,253 | $6,180 | 27.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 19 | 23 | $4,025 | $799.77 | 19.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 34 | 58 | $10,150 | $2,519 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 41 | 71 | $11,076 | $2,137 | 19.3% |
About Dr. Frank Palella, MD
Dr. Frank Palella, MD is a Infectious Disease healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952329021.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Palella, MD has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $158,205 received in 2024. These payments were reported across 1,133 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.0M).
As a Medicare-enrolled provider, Palella has provided services to 247 Medicare beneficiaries, totaling 489 services with total Medicare billing of $22,271. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Chicago, IL
- Active Since 07/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1952329021
Products in Payments
- Biktarvy (Drug) $224,068
- DOVATO (Drug) $163,333
- SYMTUZA (Drug) $109,837
- CABENUVA (Biological) $93,937
- APRETUDE (Biological) $92,727
- PREZCOBIX (Drug) $83,348
- Genvoya (Drug) $54,748
- Descovy (Drug) $51,653
- Symtuza (Drug) $38,470
- Truvada (Drug) $37,329
- ISENTRESS (Drug) $29,263
- Sunlenca (Drug) $10,365
- Serostim (Drug) $6,095
- DELSTRIGO (Drug) $5,444
- PIFELTRO (Drug) $4,084
- EGRIFTA (Drug) $4,035
- JULUCA (Drug) $3,622
- Odefsey (Drug) $2,240
- SEROSTIM (Drug) $1,455
- EVOTAZ (Drug) $500.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Chicago
Dr. Babafemi Taiwo, Md, MD
Infectious Disease — Payments: $390,320
Infectious Disease $390,320
Catherine Creticos, Md, MD
Infectious Disease — Payments: $312,981
Infectious Disease $312,981
Dr. Nancy Glick, M.d, M.D
Infectious Disease — Payments: $259,059
Infectious Disease $259,059
Dr. James Sullivan, Md, MD
Infectious Disease — Payments: $162,355
Infectious Disease $162,355
Kathleen Mullane
Infectious Disease — Payments: $156,063
Infectious Disease $156,063
Dr. Stockton Mayer, D.o, D.O
Infectious Disease — Payments: $143,746
Infectious Disease $143,746